Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study Of PF-06291874 As Oral Monotherapy To Treat Adults With Type 2 Diabetes Mellitus

NCT02175121 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

172

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type II

Interventions

DRUG: Placebo
DRUG: PF-06291874
DRUG: PF-06291874
DRUG: PF-06291874
DRUG: PF-06291874

Sponsor

Pfizer